12:00 AM
Dec 24, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Varizig regulatory update

FDA approved Varizig from Cangene to reduce the severity of chicken pox infection in high risk individuals when given within 4 days after exposure. Cangene...

Read the full 103 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >